147 related articles for article (PubMed ID: 15886874)
1. Targeting neovascular pericytes in neurofibromatosis type 1.
Ozerdem U
Angiogenesis; 2004; 7(4):307-11. PubMed ID: 15886874
[TBL] [Abstract][Full Text] [Related]
2. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
3. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
Ozerdem U; Stallcup WB
Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
5. Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1.
Imaizumi S; Motoyama T; Ogose A; Hotta T; Takahashi HE
Virchows Arch; 1998 Nov; 433(5):435-41. PubMed ID: 9849858
[TBL] [Abstract][Full Text] [Related]
6. Early contribution of pericytes to angiogenic sprouting and tube formation.
Ozerdem U; Stallcup WB
Angiogenesis; 2003; 6(3):241-9. PubMed ID: 15041800
[TBL] [Abstract][Full Text] [Related]
7. The NG2 Proteoglycan in Pericyte Biology.
Stallcup WB
Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
[TBL] [Abstract][Full Text] [Related]
8. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
10. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
11. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
Ozerdem U
Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
[TBL] [Abstract][Full Text] [Related]
12. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft.
Bhola P; Banerjee S; Mukherjee J; Balasubramanium A; Arun V; Karim Z; Burrell K; Croul S; Gutmann DH; Guha A
Int J Cancer; 2010 Jan; 126(2):563-71. PubMed ID: 19634141
[TBL] [Abstract][Full Text] [Related]
13. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
Ozerdem U; Grako KA; Dahlin-Huppe K; Monosov E; Stallcup WB
Dev Dyn; 2001 Oct; 222(2):218-27. PubMed ID: 11668599
[TBL] [Abstract][Full Text] [Related]
14. Nf1 haploinsufficiency augments angiogenesis.
Wu M; Wallace MR; Muir D
Oncogene; 2006 Apr; 25(16):2297-303. PubMed ID: 16288202
[TBL] [Abstract][Full Text] [Related]
15. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
16. The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
Gesundheit B; Parkin P; Greenberg M; Baruchel S; Senger C; Kapelushnik J; Smith C; Klement GL
J Pediatr Hematol Oncol; 2010 Oct; 32(7):548-53. PubMed ID: 20686424
[TBL] [Abstract][Full Text] [Related]
17. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
18. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
[TBL] [Abstract][Full Text] [Related]
19. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis.
Ozerdem U; Alitalo K; Salven P; Li A
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3502-6. PubMed ID: 16186326
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells.
Lee SJ; Park HJ; Kim YH; Kim BY; Jin HS; Kim HJ; Han JH; Yim H; Jeong SY
Int J Mol Med; 2012 Aug; 30(2):443-50. PubMed ID: 22664653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
